Concepedia

Publication | Open Access

Phase 1 study on the safety and efficacy of E6011, antifractalkine antibody, in patients with Crohn's disease

DOIFull Paper Access

22

Citations

20

References

2021

Year

Katsuyoshi Matsuoka, Makoto Naganuma, Toshifumi Hibi∥, Hirohito Tsubouchi, Kiyoshi Oketani, Toshinori Katsurabara, Seiichiro Hojo, Osamu Takenaka, Tetsu Kawano, Toshio Imai,
Journal of Gastroenterology and Hepatology

Abstract

E6011 was well-tolerated and might be effective in CD patients. These findings need to be clarified in a randomized controlled study.

References

YearCitations

Page 1